Amphastar Pharmaceuticals, Inc. (AMPH)
26.17
-0.61
(-2.28%)
USD |
NASDAQ |
Jan 02, 12:36
Amphastar Pharmaceuticals Research and Development Expense (TTM): 66.60M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| Align Technology, Inc. | 381.75M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| CorMedix, Inc. | 12.46M |
| Supernus Pharmaceuticals, Inc. | 104.86M |